Talis Biomedical Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Talis Biomedical Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Talis Biomedical Corp Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $161M, a 14.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $161M +$20.4M +14.5% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $140M +$29.4M +26.5% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $111M +$59.7M +116% Dec 31, 2021 10-K 2023-03-22
Q4 2020 $51.3M Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.